BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6262952)

  • 1. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doses of antibiotic in patients with renal insufficiency.
    Ohkawa M; Kuroda K
    Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function.
    Moukhtar I; Nawishy S; Sabbour M
    Chemioterapia; 1987 Feb; 6(1):38-40. PubMed ID: 3829135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis.
    Herrero A; Rius Alarcó F; García Díez JM; Mahiques E; Domingo JV
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):84-7. PubMed ID: 3045024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of moxalactam in adults].
    Humbert G; Leroy A; Fillastre JP
    Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.
    Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S
    Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin pharmacokinetics during hemodialysis in patients suffering from chronic renal failure.
    Létourneau-Saheb L; Lapierre L; Daigneault R; Prud'Homme M; St-Louis G; Serois G
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):116-20. PubMed ID: 844930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis.
    Shah PM; Knobloch M; Haag R; Kühnle HF
    Methods Find Exp Clin Pharmacol; 1982; 4(3):185-8. PubMed ID: 6289027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR; Pancorbo S; Hoag S; Bloom P
    Am J Hosp Pharm; 1980 Aug; 37(8):1077-83. PubMed ID: 7405935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefoxitin in patients undergoing hemodialysis.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Bondia Román A
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):366-70. PubMed ID: 489205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM; Pinget M; Brandt C; Lavillaureix J
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics].
    Nissenson AR; Levin NW; Parker RH
    Arzneimittelforschung; 1974 Sep; 24(9b):1470-3. PubMed ID: 4479806
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of intravenous mezlocillin in chronic hemodialysis patients.
    Francke E; Mehta S; Neu HC; Appel GB
    Clin Pharmacol Ther; 1979 Aug; 26(2):228-31. PubMed ID: 455891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.
    Appel GB; Neu HC; Parry MF; Goldberger MJ; Jacob GB
    Antimicrob Agents Chemother; 1976 Oct; 10(4):623-5. PubMed ID: 984799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis.
    Wolter K; Claus M; Wagner K; Fritschka E
    Clin Nephrol; 1994 Dec; 42(6):389-97. PubMed ID: 7882603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.